Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TRINITY BIOTECH PLC

(TRIB)
  Report
Delayed Quote. Delayed Nasdaq - 10/22 04:00:00 pm
2.1 USD   -0.47%
10/21European ADRs Move Lower in Thursday Trading
MT
10/20European ADRs Move Slightly Higher in Wednesday Trading
MT
10/19European ADRs 0.6% Higher Tuesday Morning
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Thursday Trading

09/09/2021 | 11:18am EDT


© MT Newswires 2021
All news about TRINITY BIOTECH PLC
10/21European ADRs Move Lower in Thursday Trading
MT
10/20European ADRs Move Slightly Higher in Wednesday Trading
MT
10/19European ADRs 0.6% Higher Tuesday Morning
MT
10/18European ADRs Move Lower in Monday Trading
MT
10/11European ADRs Move Higher in Monday Trading
MT
10/04European ADRs Move Lower in Monday Trading
MT
09/30TRINITY BIOTECH : Announces Results of AGM (Form 6-K)
PU
09/29European ADRs Move Higher in Wednesday Trading
MT
09/22European ADRs Climb Higher in Wednesday Trading
MT
09/17TRINITY BIOTECH : Annual General Meeting 2021 (Form 6-K)
PU
More news
Financials (USD)
Sales 2021 102 M - -
Net income 2021 12,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 4,47x
Yield 2021 -
Capitalization 43,9 M 43,9 M -
Capi. / Sales 2021 0,43x
Capi. / Sales 2022 0,42x
Nbr of Employees 543
Free-Float 69,4%
Chart TRINITY BIOTECH PLC
Duration : Period :
Trinity Biotech plc Technical Analysis Chart | TRIB | US8964383066 | MarketScreener
Technical analysis trends TRINITY BIOTECH PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 2,10 $
Average target price 7,00 $
Spread / Average Target 233%
EPS Revisions
Managers and Directors
Ronan O'Caoimh Chairman & Chief Executive Officer
John Gillard CFO, Secretary & Executive Director
Eibhlin Kelly Chief Information Officer
Clinton H. Severson Lead Independent Non-Executive Director
James D. Merselis Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
TRINITY BIOTECH PLC-44.62%44
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.57.22%21 518
10X GENOMICS, INC.15.84%18 189
BIOMÉRIEUX-9.53%14 370
DIASORIN S.P.A.11.05%12 023
NATERA, INC.15.48%10 778